Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001974078-24-000537
Filing Date
2024-12-16
Accepted
2024-12-16 15:08:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2890
  Complete submission text file 0001974078-24-000537.txt   4629
Mailing Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746
Business Address 6836 BEE CAVE ROAD BUILDING 3, SUITE 201 AUSTIN TX 78746 51285113796
Savara Inc (Subject) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-32157 | Film No.: 241551526
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 422 WILLIAM WALLACE DRIVE FRANKLIN TN 37064
Business Address
Lowrance David L (Reporting) CIK: 0001408498 (see all company filings)

Type: 144